You searched for "litigation"
Happy hour
Welcome Eye News Aug/Sep 2023, your bi-monthly tonic for a much-needed happy hour. In the current climate of challenge across all fronts, there’s no better time to reach out for the professional equivalent of a cheery cup in the company...Severe conjunctival cicatrisation secondary to chronic glaucoma therapy
The timing of glaucoma filteration surgery during the course of chronic progressive glaucoma remains a contentious issue amongst glaucoma specialists. The vast majority support the use of maximal medical treatment initially to achieve the target pressure. Surgical procedures are only...My Top Five: Social movements changing eyecare awareness
Throughout recent years, the rise of the digital age has allowed for social movements to receive far greater awareness than was ever deemed possible. As a result, significant attention has been drawn towards initiatives focusing on a range of health...OrCam MyEye – innovative sight assistance (Part 2)
Following on from Part 1 of this topic, we will cover the remaining features, pricing and support of the OrCam MyEye. Facial and person identification The MyEye Pro can be taught to recognise up to 150 individuals (or 75 if...
The use of adalimumab for relapse in patients with Vogt-Koyanagi-Harada disease
In this retrospective, multi-centre, cohort study, the efficacy and safety of Adalimumab (ADA) treatment for the exacerbation or recurrence of Vogt-Koyanagi-Harada (VKH) patients was assessed by investigating the medical records of patients who had received ADA treatment for more than...Tech supplier search to help tackle 8am rush at GP surgeries
Tech specialists are being sought to help tackle the 8am rush for appointments at GP surgeries.Tackling diabetic retinopathy globally through the VISION 2020 LINKS Diabetic Retinopathy Network
It is abundantly clear that the burden of diabetes is rapidly increasing, as there are now 415 million adults with diabetes in the world, with a projected rise to 642 million by 2040 [1]. This equates to 1 in 10...
Intracameral bevacizumab as an adjunct to trabeculectomy
This is a 12-month, prospective, randomised, double-masked, placebo-controlled trial of patients who were not controlled medically with open angle glaucoma and scheduled for a primary trabeculectomy. Patients were recruited and randomised during the period between April 2009 and November 2010....
